ItchBio
PrivateCompany Overview
ItchBio is a clinical-stage biotechnology company developing topical, non-steroidal therapeutics for the treatment of chronic itch.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverypruritus treatmentdermatology therapeuticsbiotech startupsmall molecule therapeuticsclinical developmentchronic itchatopic dermatitisbiologic therapeuticsdrug pipelineinflammatory skin diseasebiotech licensingR&D
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ItchBio Comparables
Compare ItchBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tharimmune, Inc. | 78% | |
| Tvardi | 78% | |
| AOBiome Therapeutics Inc. | 74% | |
ItchBio Funding Rounds
Historical fundraising activity
ItchBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ItchBio's valuation, stock price, and market status.
See something wrong or outdated?